LKeithSimmonsDO

PubMed

• N(8)-acetylspermidine as a potential plasma biomarker for Snyder-Robinson syndrome identified by clinical metabolomics.
  Abela L, Simmons L, Steindl K, Schmitt B, Mastrangelo M, Joset P, Papuc M, Sticht H, Baumer A, Crowther LM, Mathis D, Rauch A, Plecko B> ;J. Inherit. Metab. Dis.. 2016-01-01
• Suppression of an amyloid beta peptide-mediated calcium channel response by a secreted beta-amyloid precursor protein.
  Li, W.Y., Butler, J.P., Hale, J.E., McClure, D.B., Little, S.P., Czilli, D.L., Simmons, L.K.> ;Neuroscience. 2000
• Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons.
  Du, Y., Bales, K.R., Dodel, R.C., Hamilton-Byrd, E., Horn, J.W., Czilli, D.L., Simmons, L.K., Ni, B., Paul, S.M.> ;Proc Natl Acad Sci U S A. 1997 Oct 14
• 8 citations
  Evaluation of Antibiotic Efficacy Using Electron Microscopy: Morphological Effects of Guanylureido Cephalosporin, Chlorobenzoylureido Cephalosporin, BL-P1654, and Carb...
  L. F. Ellis, D. K. Herron, David A. Preston, L. K. Simmons, R. A. Schlegel> ;Antimicrobial Agents and Chemotherapy. 1976 Feb 1
• Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
  Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N.> ;Mol Pharmacol. 1994 Mar
• beta-Amyloid peptide in vitro toxicity: lot-to-lot variability.
  May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., Robison, P. M.> ;Neurobiol Aging. 1992 Sep 01
• Neuronal membrane conductance activated by amyloid beta peptide: importance of peptide conformation.
  Li, W. Y., Czilli, D. L., Simmons, L. K.> ;Brain Res. 1995 Jun 5
• Join now to see all